Diabetes Clinical Trials in Massachusetts

Showing 61-80 of 610 trials

Social Needs Screening and Chronic Diseases Study (WE CARE)

NCT06903897

The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertension, diabetes, depression, hyperlipidemia, and asthma through clinical measures. The main question it aims to answer is: Does the WE CARE SDOH screening and referral intervention applying an antiracism lens informed implementation strategies have the potential to reduce racial/ethnic health inequities in chronic diseases for minoritized patients?

HyperlipidemiasDiabetesDepression+2 more

University of Massachusetts, Worcester68,000 participantsStarted Oct 2025

Worcester, Massachusetts, United States • Worcester, Massachusetts, United States • Worcester, Massachusetts, United States

RECRUITINGNA14 miles

Continuous Glucose Monitor Use in Pregnancy

NCT05317585

The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.

Type 2 Diabetes Treated With InsulinPregnancy, High Risk

University of Massachusetts, Worcester180 participantsStarted May 2024

Worcester, Massachusetts, United States

Social Needs Screening and Chronic Diseases Study (WE CARE)

Continuous Glucose Monitor Use in Pregnancy

Diabetes Trials in Other Cities

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

Effects of My Diabetes Care on Patient Outcomes

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Decision Support for Detection of Chronic Kidney Disease in Type II Diabetes Mellitus

Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims

Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data

A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

Multicenter Assessment of the Pancreas in Type 1 Diabetes

Other Conditions in Massachusetts